Thymic carcinoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Medical Therapy== | ==Medical Therapy== | ||
Treatment options include the following: | Treatment options include the following: | ||
Surgery | *Surgery | ||
Radiation | *Radiation | ||
Multimodality approach, such as: | Multimodality approach, such as: | ||
Surgical resection | *Surgical resection | ||
Radiation therapy | *Radiation therapy | ||
Cisplatin-based chemotherapy | *Cisplatin-based chemotherapy | ||
==References== | ==References== | ||
Revision as of 16:07, 4 January 2016
|
Thymic Carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Thymic carcinoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Thymic carcinoma medical therapy |
|
Risk calculators and risk factors for Thymic carcinoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Overview
The predominant therapy for thymic carcinoma is surgical resection. Adjunctive cisplatin-basedchemotherapy may be required.
Medical Therapy
Treatment options include the following:
- Surgery
- Radiation
Multimodality approach, such as:
- Surgical resection
- Radiation therapy
- Cisplatin-based chemotherapy